Webinar on Cell Therapy Research will be hosted on February 10th, 2021. Panel of speakers will be delivering their presentations on their recent research related to Cell Therapy Research. Current state of knowledge, its impact on future will be discussed in detailed. Meetings International invites all experts to be part this webinar series and make it a perfect platform for experiencing and knowledge.
Session -1 Cell Therapies: Cell therapy may be defined as the treatment or prevention of disease by administration of cells that have been selected, manipulated, or altered outside the body. Using this definition, we see that cell-based therapeutic products have been used in the clinic for nearly 90 years in the form of blood transfusions and 50 years in the form of bone marrow transplants.
CAR T-cell therapy is a form of immunotherapy that uses specially altered T cells ‘a part of the immune system’ to fight cancer. A sample of a patient's T cells are collected from the blood, and then modified to produce special structures called chimeric antigen receptors (CARs) on their surface.
Session -2 Cells and Gene Therapy : Cell and gene therapies are a transformative new category of medicines whose full potential is only just beginning to emerge.
Cell and gene therapies are different. They involve extracting cells, protein or genetic material (DNA) from the patient (or a donor), and altering them to provide a highly personalised therapy, which is re-injected into the patient. Cell and gene therapies may offer longer lasting effects than traditional medicines. They have the potential to address complex diseases, such as motor neurone disease, and many rare disorders for which there are no effective treatments. In their simplest form, these therapies work by replacing a faulty or missing gene that causes an inherited condition, such as sickle cell anaemia or cystic fibrosis. Cell therapy is targeted at many clinical indications in multiple organs and by several modes of cell delivery.
Session-3 Cell Therapy strategy and Transplantation:
Allogeneic Cell Therapy: In allogeneic cell therapy the donor is a different person to the recipient of the cells. In pharmaceutical manufacturing, the allogeneic methodology is promising because unmatched allogeneic therapies can form the basis of "off the shelf" products. There is research interest in attempting to develop such products to treat conditions including Crohn’s disease and a variety of vascular conditions.
Autologous Cell Therapy: In autologous cell therapy, cells are transplanted that are derived from the patient’s own tissues. Multiple clinical studies are ongoing that obtain stromal cells from bone-marrow, adipose tissue, or peripheral blood to be transplanted at sites of injury or stress; which is being actively explored. It could also involve the isolation of matured cells from diseased tissues, to be later re-implanted at the same or neighboring tissues; a strategy being assessed in clinical trials.
Xenogeneic Cell Therapy: In xenogeneic cell therapies, the recipient will receive cells from another species. For example, the transplantation of pig derived cells to humans. Currently, xenogeneic cell therapies primarily involve human cell transplantation into experimental animal models for assessment of efficacy and safety. However future advances could potentially enable xenogeneic strategies to humans as well.
Cell Transplantation: Cell transplantation is a procedure in which cells that can be induced to become pluripotent stem cells, are transferred to a site where the tissue is damaged or diseased. The transfer can occur within an individual, between individuals, or between species. Cells can be treated before implantation.
Session -4 Immune Cell Therapy: Immuno cell therapy has emerged as an exciting new approach to cancer treatment that is yielding unprecedented, durable responses for patients with an increasingly diverse array of cancer types. Much of the excitement has centered around checkpoint inhibitors, immuno therapeutics that release the “brakes” on the surface of immune cells called T cells, some of which are naturally capable of destroying cancer cells. Immunotherapy involves engineering patients’ own immune cells to recognize and attack their tumors. And although this approach, called adoptive cell transfer (ACT), has been restricted to small clinical trials so far, treatments using these engineered immune cells have generated some remarkable responses in patients with advanced cancer. .Adoptive T cell therapy for cancer is a form of transfusion therapy consisting of the infusion of various mature T cell subsets with the goal of eliminating a tumor and preventing its recurrence.
Session-5 Adaptive Cell Therapy: Adoptive cell therapy is a complex medical procedure that is customized for each patient. It begins with the extraction of T cells. In the laboratory, these T cells are either genetically modified to target tumor-specific antigens and then expanded or are expanded based on their natural tumor reactivity. Once enough T cells have been generated, they are infused back into the patient to help mediate tumor regression.
There are several different types of adoptive cell therapy. One approach utilizes tumor-infiltrating lymphocytes (TILs) that are isolated from a patient’s tumor, expanded in number in the laboratory, and infused back into the patient. A second approach is to engineer the T cells harvested from a patient to express a tumor antigen–specific T-cell receptor (TCR) so that the T cells can recognize and attack tumor cells that express such antigens.
Session -6 The Future: There are countless indications for cell therapy which have very real promise in numerous fields. This could concern clinical fields such as neurodegenerative diseases (Parkinson's or Alzheimer's disease) or muscle degeneration (Duchenne muscular dystrophy) if researchers are able to produce large quantities of different neuron sub-types and skeletal muscle cells. Dare we also envisage the possibility of producing blood cells, including platelets, in unlimited quantities to cover hospital blood needs? All hypotheses are now on the table.
The Cell Therapy market is relied upon to reach $9.76 billion by 2026 developing at a CAGR of 7.2% from 2018 to 2026. Cell treatment is an innovation which depends on replacing the diseased or deteriorated cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy finds its application in the development of regenerative medicines which is a multidisciplinary area aimed at maintenance, improvement, or restoration of a cell, tissue, or organ function using methods mainly related to cell therapy.
Factors, for example, rising subsidizing from the legislature just as private associations to help cell treatment clinical preliminaries, developing reception of regenerative medication and increment in the occurrence of sicknesses, for example, malignancy, cardiovascular irregularities are fuelling the market development. Nonetheless, the usage of tough government guidelines with respect to the utilization of cell treatment is foreseen to confine the development of the market. By Therapy Type, Autologous treatments will have a noteworthy rate during the forecast period owing to several advantages offered by them, for example, accessibility, lower risk of life threatening difficulties, low pace of grift failure, low death rate, higher affordability and high survival rate of patients. Autologous cell treatment is a part of regenerative medication. It includes biologic cell-based treatments to fix different ailments identified with oncology, dermatology, and nervous system science, among others.
Top Universities of the World
Top Universities of Asia
Top Universities of US
Top Universities of Europe:
Global Entrepreneur Societies:
Webinar on Cell Therapy
November 21, 2020
Young Scientist Awards at Cell Therapy 2020 for the Best researches in Cell Therapy Research.
Meetings International is announcing Young Scientist Awards Cell Therapy Research 2020 which is scheduled during November 21st.
Cell Therapy 2020 and upcoming conferences will recognise participants who have significantly added value to the scientific community of environmental science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.
Cell Therapy Research focuses mainly on Cell Therapy, Gene Therapy, Molecular Medicine, Immunotherapy, Genetic Medicine. Cell Therapy conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.
Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. candidates. Persons from Scientific Industry can also participate.
Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.
o Acknowledgement as YRF Awardee
o Promotion on the conference website, Young Researcher Awards and certificates
o Link on the conference website
o Recognition on Meetings Int. Award Page
o Chances to coordinate with partners around the world
o Research work can be published in the relevant journal without any publication fee
o All presented abstracts will automatically be considered for the Award.
o All the presentation will be evaluated in the conference venue
o All the awards will be selected by the judges of the award category
o The winners of the Young Scientist Award will receive award certificate.
o The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.
o All submissions must be in English.
o The topic must fit into scientific sessions of the conference
o Each individual participant is allowed to submit maximum 2 papers
o Abstract must be submitted online as per the given abstract template
o Abstracts must be written in Times New Roman and font size will be 12
o Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference
Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of award.
Official announcement of the recipients will occur after the completion of Cell Therapy Webinar.
Learning In a New Space
New Tips & Tactics